Mohammed A. M. Alhoot | Molecular Microbiology | Outstanding Scientist Award

Assoc. Prof. Dr. Mohammed A. M. Alhoot | Molecular Microbiology | Outstanding Scientist Award

Associate Professor of Medical Microbiology & Immunology at Management and Science University, Malaysia

Assoc. Prof. Dr. Mohammed AbdelFatah Mosa Al-Hoot is an accomplished academic and researcher in Medical Microbiology and Immunology, specializing in Virology and Molecular Microbiology. With a career spanning over two decades, he has made significant contributions to molecular virology, antiviral therapeutics, antimicrobial resistance, nanoparticle-based treatments, and infectious diseases. His research on dengue virus inhibition through siRNA and antiviral peptides, as well as nanoparticle antibacterials and phytochemical antiviral screening, has been widely recognized. He has authored more than 40 peer-reviewed publications, contributed book chapters, and holds a patent, with his work attracting over 600 citations globally. A leader in postgraduate supervision, curriculum development, and research ethics, Dr. Al-Hoot also serves as an editor and reviewer for international journals. His collaborative projects across countries, commitment to capacity building, and contributions to scientific knowledge have positioned him as a respected figure in the global research community.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Al-Hoot’s academic journey reflects a strong foundation in medical sciences and research excellence. He earned his Bachelor’s degree with honors in Medical Laboratory Sciences, followed by a Master’s in Microbiology, both of which equipped him with essential skills in laboratory diagnostics and infectious disease analysis. Building on this expertise, he pursued and completed a Ph.D. in Medical Microbiology, specializing in Medical Virology, at a leading university. His doctoral research focused on innovative antiviral strategies, laying the groundwork for his subsequent contributions to molecular virology and translational therapeutics. Throughout his education, Dr. Al-Hoot consistently demonstrated academic distinction, earning scholarships and recognition for his scholarly performance. His academic qualifications have provided a strong platform for his research in virology, antimicrobial resistance, and nanoparticle therapeutics, enabling him to bridge fundamental science with applied biomedical solutions. His education has also shaped his teaching and mentorship, fostering future leaders in the microbiology and biomedical fields.

Experience

Dr. Al-Hoot’s professional career spans extensive academic, research, and clinical laboratory roles, reflecting his versatility and leadership in medical microbiology. He has served as an Associate Professor at a reputed Malaysian university, where he has been actively involved in teaching, research supervision, curriculum coordination, and academic leadership. His experience includes managing and leading numerous research projects, both as principal investigator and collaborator, with international partners. Over the years, he has successfully supervised numerous Ph.D. and Master’s students to completion, contributing to global research capacity building. His professional journey also encompasses significant editorial and peer review responsibilities for high-impact scientific journals, ensuring the quality of published research in his field. In addition to his academic work, he has engaged in community outreach, research ethics committees, and scientific event organization. This multifaceted experience underscores his ability to integrate research, teaching, and service for impactful contributions to science and society.

Research Interest

Dr. Al-Hoot’s research interests lie at the intersection of molecular virology, antimicrobial resistance, and innovative therapeutic approaches. He focuses on developing antiviral strategies targeting viral entry and replication, particularly for dengue virus and other significant pathogens. His work explores the use of small interfering RNA (siRNA), synthetic antiviral peptides, and natural products as novel therapeutics. Additionally, he investigates nanoparticle-based antibacterial agents and their role in combating drug-resistant microorganisms. His interests also extend to diagnostic microbiology, infectious diseases, and gut microbiota modulation. By integrating molecular biology techniques with translational applications, Dr. Al-Hoot aims to address global health challenges through innovative, sustainable, and effective solutions. His interdisciplinary research approach fosters collaboration between microbiology, nanotechnology, pharmacology, and clinical sciences, ensuring that his work remains relevant to both scientific advancement and public health needs. These interests continue to guide his projects, publications, and mentorship of emerging researchers in the field.

Awards and Honors

Dr. Al-Hoot’s excellence in research and academia has been recognized through numerous awards and honors. He has received the University of Malaya Excellence Award for his outstanding contributions to scientific research, as well as prestigious scholarships, including the MIS Scholarship during his doctoral studies. His institution has honored him with multiple service excellence recognitions, acknowledging his dedication to teaching, research, and community service. He has been invited as a keynote speaker and panelist at international conferences, reflecting the high regard for his expertise in virology and antimicrobial research. His editorial roles in globally recognized journals and active involvement in peer review further underscore his professional standing. Additionally, his contributions to collaborative projects and research ethics committees have earned him respect within the academic community. These accolades not only celebrate his past achievements but also highlight his continuing commitment to advancing microbiology and immunology for societal benefit.

Research Skills

Dr. Al-Hoot possesses a diverse and advanced skill set in medical microbiology, molecular virology, and infectious disease research. His technical expertise includes RNA interference, synthetic antiviral peptide development, nanoparticle synthesis for antimicrobial applications, molecular diagnostics, and advanced microbiological assays. He is proficient in designing and conducting translational research studies that bridge laboratory findings to clinical applications. His skills extend to grant writing, securing competitive funding, and leading multi-institutional and international research collaborations. In the academic sphere, he excels in curriculum design, postgraduate supervision, and mentorship, fostering the next generation of researchers. His editorial and peer-review experience with high-impact journals demonstrates his ability to critically evaluate scientific work and maintain research integrity. Additionally, his involvement in organizing scientific conferences and workshops highlights his capabilities in knowledge dissemination and community engagement. Collectively, these skills enable him to contribute significantly to both scientific discovery and the broader biomedical research ecosystem.

Publications Top Notes

Title: Autophagy and Senescence: A New Insight in Selected Human Diseases
Authors: P. Rajendran, A.M. Alzahrani, H.N. Hanieh, S.A. Kumar, R. Ben Ammar, M.A. Alhoot, and others
Year: 2019
Citations: 128

Title: Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides
Authors: M.A. Alhoot, A.K. Rathinam, S.M. Wang, R. Manikam, S.D. Sekaran
Year: 2013
Citations: 83

Title: Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA Interference
Authors: M.A. Alhoot, S.M. Wang, S.D. Sekaran
Year: 2011
Citations: 70

Title: RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells
Authors: M.A. Alhoot, S.M. Wang, S.D. Sekaran
Year: 2012
Citations: 66

Title: Isolation and Screening of Extracellular Protease Enzyme from Fungal Isolates of Soil
Authors: A.M.A. Maitig, M.A.M. Alhoot, K. Tiwari
Year: 2018
Citations: 50

Title: Genetic Diversity of Fungi Producing Mycotoxins in Stored Crops
Authors: F.E.M. Eltariki, K. Tiwari, I.A. Ariffin, M.A. Alhoot
Year: 2018
Citations: 23

Title: An Association between Khat and Diabetes
Authors: A.M. El Hadrani, M.A. Alhoot
Year: 2000
Citations: 23

Title: Climate Change and Health: The Malaysia Scenario
Authors: M.A. Alhoot, W.T. Tong, W.Y. Low, S.D. Sekaran
Year: 2016
Citations: 21

Conclusion

Assoc. Prof. Dr. Mohammed AbdelFatah Mosa Al-Hoot is a distinguished scientist in Medical Microbiology and Immunology, with specialization in Virology and Molecular Microbiology. His research covers molecular virology, antiviral therapeutics, antimicrobial resistance, nanoparticle-based treatments, and infectious diseases, with notable work on dengue virus inhibition through siRNA and antiviral peptides, as well as nanoparticle antibacterials and phytochemical antiviral screening. He holds advanced degrees in medical microbiology and has extensive academic and clinical experience, contributing significantly to education and research. He has led and collaborated on multiple funded projects across several countries, producing over 40 peer-reviewed publications, book chapters, and a patent, with substantial citations. Serving as an editor and reviewer for international journals, he actively advances research quality. His leadership includes curriculum development, postgraduate supervision, ethics committee service, and organizing academic events. Dedicated to mentorship, collaboration, and innovation, he has made impactful contributions to science, capacity building, and the global research community.

Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Prof. Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Professsor at Tabriz University of Medical Sciences, Iran

Prof. Mehdi Yousefi, Associate Professor of Immunology at Tabriz University of Medical Sciences, is a distinguished researcher with an exceptional track record in immunology, reproductive immunology, autoimmune diseases, and cancer immunotherapy. With over a decade of academic and research experience, Prof. Yousefi has published extensively in high-impact journals, earning a Scopus H-index of 58 and a Google Scholar H-index of 71, placing him among the top 1% of highly cited researchers globally. His innovative contributions include several patents on human antibody fragments and advanced biomedical tools, reflecting his strong focus on translational research. Prof. Yousefi has been recognized multiple times as a Top Researcher by Tabriz University of Medical Sciences and has received the prestigious national Razi Award. Through his leadership, collaborative research, and commitment to advancing immunological science, Prof. Yousefi has made significant contributions to both basic and applied biomedical research, enhancing the scientific community’s understanding of immune-related diseases.

Professional Profile 

Education

Prof. Mehdi Yousefi has a strong and distinguished educational background in medical sciences, particularly in immunology. He earned his Bachelor’s degree (B.Sc.) in Medical Laboratory Technology from Tehran University of Medical Sciences in 2004, where he demonstrated academic excellence. He continued his studies at the same university, completing his Master’s degree (M.Sc.) in Immunology in 2007, where he ranked first in the national entrance exam for the program. Building on his passion for immunological research, Prof. Yousefi pursued a PhD in Immunology, also at Tehran University of Medical Sciences, and graduated in 2013 with the highest possible score (20 out of 20). His PhD research focused on humoral immune responses against tetanus toxin at the single-cell level, showcasing his expertise in immunological techniques and innovative approaches to studying immune mechanisms. His consistent academic excellence, top rankings, and commitment to scientific research laid a strong foundation for his successful career in immunology and medical sciences.

Professional Experience

Prof. Mehdi Yousefi has built an impressive professional career rooted in both academic excellence and cutting-edge research. Since 2013, he has served as an academic and research member at the Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, where he currently holds the position of Associate Professor of Immunology. His professional focus spans a wide range of areas, including reproductive immunology, autoimmune diseases, rheumatic disorders, and cancer immunotherapy. Prof. Yousefi has played a pivotal role in mentoring students, leading collaborative research projects, and contributing to the development of advanced immunological diagnostics and therapies. His innovative work has resulted in numerous patents, particularly in the field of antibody fragment development and cancer targeting, demonstrating his ability to bridge fundamental science with clinical applications. Through his leadership, prolific publications, and active participation in the scientific community, Prof. Yousefi has established himself as a respected and influential figure in immunology research.

Research Interest

Prof. Mehdi Yousefi’s research interests focus on understanding the complex mechanisms of the immune system and its role in health and disease. His primary areas of interest include reproductive immunology, where he investigates the immune system’s involvement in pregnancy complications and maternal-fetal tolerance. He also conducts extensive research on autoimmune diseases and rheumatic disorders, aiming to uncover the immunopathological mechanisms driving these conditions to develop more targeted therapies. In addition, Prof. Yousefi has a strong focus on cancer immunotherapy, particularly the development of novel antibody fragments and immunomodulatory approaches for treating cancers such as breast and colorectal cancer. His work also extends to neurosciences, where he explores the immune system’s interactions with the nervous system in neuroinflammatory and neurodegenerative diseases. Through his multidisciplinary approach, combining basic immunology, translational research, and clinical applications, Prof. Yousefi aims to advance immunological knowledge and develop innovative diagnostic and therapeutic strategies for immune-related disorders.

Award and Honor

Prof. Mehdi Yousefi has received numerous prestigious awards and honors, recognizing his outstanding contributions to immunology and biomedical research. He has been repeatedly honored as the Top Researcher at Tabriz University of Medical Sciences in 2014, 2015, 2017, 2020, and 2021, reflecting his consistent excellence in scientific output and impactful research projects. In 2020, he was further recognized at the national level with the prestigious Razi Award, one of the highest honors for medical research in Iran. In 2022, Prof. Yousefi’s global impact was highlighted when he was named among the Top 1% Highly Cited Researchers (ESI), a distinction that underscores the international significance and influence of his publications. These accolades, combined with his numerous patents and his leadership in innovative research projects, demonstrate Prof. Yousefi’s dedication, creativity, and commitment to advancing immunological science, both within Iran and on the global stage.

Research skill

Prof. Mehdi Yousefi possesses a diverse and advanced set of research skills that have enabled him to excel in the fields of immunology, molecular biology, and translational medicine. His expertise includes designing and conducting immunological assays, such as flow cytometry, ELISA, and cell culture techniques, which he applies to study immune responses in conditions ranging from autoimmune diseases to cancer immunotherapy. He has extensive experience in monoclonal antibody development, including phage display technology for the generation of scFv antibody fragments, which has led to several patents. Prof. Yousefi is also skilled in molecular techniques, such as PCR, gene cloning, and gene expression analysis, which he applies to study immune signaling pathways and immune cell interactions. His collaborative approach, combined with strong project management and scientific writing skills, has resulted in numerous high-impact publications and successful research collaborations, making him a well-rounded and innovative researcher in the field of immunology.

Conclusion

His exceptional publication record, high citation impact, consistent institutional and national awards, and innovative patented research make him a top candidate. His breadth of expertise, from immunology to translational medicine, and his proven track record of impactful research across various fields position him strongly for this recognition

Publications Top Noted

  • The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial
    Authors: Badihi E., Sharifi P., Kamrani A., Aghebati-Maleki L., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Impact of lymphocyte immunotherapy (LIT) on fertility rates in recurrent pregnancy loss (RPL) women with antinuclear antibodies: A randomized clinical trial
    Authors: Dashti M., Kamrani A., Shahir-Khajeh Z., Mehdizadeh A., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2025
    Citations: 0

  • Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies
    Authors: Ebrahimi R., Asghari K.M., Alamdary S.J., Hojjat-Farsangi M., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • The role of probiotics in restoring the Th1 to Th2 ratio in women experiencing recurrent implantation failure; a double-blind randomized clinical trial
    Authors: Kamrani A., Asghari K.M., Zafarani Y., Zolfaghari M.A., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Investigating the effect of echinacea extraction syrup on the outcomes of lower respiratory infections in patients with COVID-19: a randomized clinical trial study
    Authors: Kheirandish E., Mahdizadeh M., Mahdizadeh M., Yousefi M., Shojaee S.S.R.
    Journal: Virology Journal
    Year: 2024
    Citations: 0

  • Cyclosporine and fedratinib combination therapy via modulating Th17/Treg balance in Rat model of membranous glomerulonephritis
    Authors: Ghassabi A., Hosseini M., Abdoli Goungormaz H., Etemadi J., Yousefi M.
    Journal: Biochemistry and Biophysics Reports
    Year: 2024
    Citations: 0

  • The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
    Authors: Sadeghi M., Moslehi A., Kheiry H., Movassaghpuor A.A., Niaragh F.J.
    Journal: Cancer Cell International
    Year: 2024
    Citations: 2

  • Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women
    Authors: Shekarchi A.A., Hosseini L., Kamrani A., Ahmadian Heris J., Yousefi M.
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 0

  • Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine
    Authors: Asghari K.M., Novinbahador T., Mehdizadeh A., Zolfaghari M.A., Yousefi M.
    Journal: Heliyon
    Year: 2024
    Citations: 0

  • Analysis of Th17 cell population and expression of microRNA and factors related to Th17 in patients with premature ovarian failure
    Authors: Nouri N., Aghebati-Maleki L., Zangbar M.S.S., Chakari-Khiavi F., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2024
    Citations: 2